↑Ma X, Wright J, Dou S, Olsen P, Teeter L, Adams G, Graviss E (Apr 2002). "Ethnic divergence and linkage disequilibrium of novel SNPs in the human NLI-IF gene: evidence of human origin and lack of association with tuberculosis susceptibility". J Hum Genet. 47 (3): 140–5. doi:10.1007/s100380200016. PMID11950066.
↑Yeo M, Lin PS, Dahmus ME, Gill GN (Jul 2003). "A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5". J Biol Chem. 278 (28): 26078–85. doi:10.1074/jbc.M301791200. PMID12721286.
Marquet S, Lepage P, Hudson TJ, et al. (2000). "Complete nucleotide sequence and genomic structure of the human NRAMP1 gene region on chromosome region 2q35". Mamm. Genome. 11 (9): 755–62. doi:10.1007/s003350010151. PMID10967134.
Fernandes AO, Campagnoni CW, Kampf K, et al. (2004). "Identification of a protein that interacts with the golli-myelin basic protein and with nuclear LIM interactor in the nervous system". J. Neurosci. Res. 75 (4): 461–71. doi:10.1002/jnr.10882. PMID14743429.
Yeo M, Lee SK, Lee B, et al. (2005). "Small CTD phosphatases function in silencing neuronal gene expression". Science. 307 (5709): 596–600. doi:10.1126/science.1100801. PMID15681389.
Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID16189514.
Sapkota G, Knockaert M, Alarcón C, et al. (2007). "Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways". J. Biol. Chem. 281 (52): 40412–9. doi:10.1074/jbc.M610172200. PMID17085434.